Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells

Attenuated measles viruses (MV) are assessed in clinical trials for their capacity to preferentially infect and kill tumor cells. We recently showed that MV-infected tumor cells are able to activate tumor antigen cross-presentation by myeloid and plasmacytoid dendritic cells. Thus, MV-based antitumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonteneau, Jean-François, Guillerme, Jean-Baptiste, Tangy, Frédéric, Grégoire, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667908/
https://www.ncbi.nlm.nih.gov/pubmed/23762802
http://dx.doi.org/10.4161/onci.24212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667908/
https://www.ncbi.nlm.nih.gov/pubmed/23762802
http://dx.doi.org/10.4161/onci.24212

Ejemplares similares